News Clinical Trial Evaluates Promising Immunotherapy Combination For Metastatic Triple Negative Breast Cancer
News Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant
News Roswell Park-led Team Finds New Evidence Why Some Targeted Therapies Support Better Response to Cancer Immunotherapy
Video First-in-Human Clinical Trial for B-cell Lymphoma Using “Armored” CAR T Cells Opens at Roswell Park
News Roswell Park Clinical Trials Offer Novel Immunotherapies for Advanced/Metastatic Tumors, Refractory Melanoma
News Study Compiling Outcomes of 17,000 Cancer Patients Highlights Need for Careful Treatment Planning, Monitoring